Metropolis Healthcare plunges 23% in two days on disappointing Q3 results

In Q4FY22, the company expects better profitability on account of higher QoQ volumes from large government contract and benefits of investments in digitization and marketing.

Shares of Metropolis Healthcare continued to reel under pressure for a second straight day, down 9 per cent at Rs 1,870.90 on the BSE in Tuesday’s intra-day trade. The stock has fallen 23 per cent in the past two trading days after the company reported a disappointing set of numbers for the December quarter (Q3FY22).

At 01:58 pm; the stock was trading 4 per cent lower at Rs 1,965, as compared to a 2.4 per cent rally in the S&P BSE Sensex. The trading volumes on the counter jumped four-fold with a combined 2.5 million equity shares having changed